Company research / CAI
Caris Life Sciences, Inc. (CAI)
- Sector Services
- Incorporated TX
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Caris Life Sciences, Inc. reported revenue of $812.03M. Revenue grew 97.0% from the prior annual period.
Key ratios (year ended 2025-12-31)
5.6%
Operating margin
-8.4%
Net margin
-11.8%
Return on year-end equity
97.0%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.